Tarsus Pharmaceuticals TARS
NASDAQ TARS
$73.83 +2.99 (+4.22%)
At close: Nov 10, 2026 · 4:00 PM EST

Tarsus Pharmaceuticals (TARS) Total Non-Current Liabilities (2019 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) reported Total Non-Current Liabilities of $252.39 million for Q3 2026, up 33.3% from $189.33 million a year earlier and up 1.6% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Tarsus Pharmaceuticals posted Total Non-Current Liabilities of $208.13 million, up 36.5% from FY2024.

  • Total Non-Current Liabilities has increased for five consecutive years, with a five-year compound annual growth rate of 107.7% (FY2020 to FY2025).
  • By year, Total Non-Current Liabilities came in at $152.46 million in FY2024 (+128.4%), $66.76 million in FY2023 (+91.5%), $34.86 million in FY2022 (+203.7%) and $11.48 million in FY2021 (+113.1%).
  • The Q3 2026 figure ranks as the highest quarterly Total Non-Current Liabilities in data going back to Q4 2019.
  • Over the past five years, the year-over-year growth in Total Non-Current Liabilities ranged from 18.8% (Q1 2023) to 224.4% (Q3 2022).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $248.52 million (Q2 2026), $216.11 million (Q1 2026) and $208.13 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 102.65 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 117.60 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 33.91 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 36.05 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 96.04 Bn
10 Tarsus Pharmaceuticals 3.35 Bn 2.41 Bn 180.68 Mn 252.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 252.39 Mn
Jun 30, 2026 248.52 Mn
Mar 31, 2026 216.11 Mn
Dec 31, 2025 208.13 Mn
Sep 30, 2025 189.33 Mn
Dec 31, 2024 152.46 Mn
Sep 30, 2024 137.58 Mn
Jun 30, 2024 123.15 Mn
Mar 31, 2024 72.46 Mn
Dec 31, 2023 66.76 Mn
Sep 30, 2023 52.96 Mn
Jun 30, 2023 39.37 Mn
Mar 31, 2023 37.77 Mn
Dec 31, 2022 34.86 Mn
Sep 30, 2022 33.63 Mn
Jun 30, 2022 30.98 Mn
Mar 31, 2022 31.79 Mn
Dec 31, 2021 11.48 Mn
Sep 30, 2021 10.37 Mn
Jun 30, 2021 10.46 Mn
API Access

Tarsus Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=TARS&period=max&api_key=YOUR_API_KEY